Home › Trial NCT00003892
ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
- Trial IDNCT00003892
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorNCIC Clinical Trials Group
- Enrollment22
- Start date1999-02-01
- ConditionsOvarian Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.